MIFH
ABBV icon

Migdal Insurance & Financial Holdings’s AbbVie ABBV Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.6M Buy
412,152
+80,450
+24% +$17.8M 0.78% 36
2025
Q4 		$75.8M Buy
331,702
+75,103
+29% +$17.1M 0.65% 33
2025
Q3 		$59.4M Buy
256,599
+126,024
+97% +$25.7M 0.64% 34
2025
Q2 		$24.2M Buy
130,575
+130,043
+24,444% +$24.2M 0.29% 61
2025
Q1 		$111K Sell
532
-1,504
-74% -$292K ﹤0.01% 244
2024
Q4 		$362K Sell
2,036
-326
-14% -$59.9K 0.01% 184
2024
Q3 		$466K Sell
2,362
-186
-7% -$34.7K 0.01% 178
2024
Q2 		$436K Sell
2,548
-871
-25% -$144K 0.01% 186
2024
Q1 		$623K Sell
3,419
-7,685
-69% -$1.32M 0.01% 163
2023
Q4 		$1.72M Buy
11,104
+7,661
+223% +$1.12M 0.03% 123
2023
Q3 		$518K Buy
3,443
+1,420
+70% +$208K 0.01% 186
2023
Q2 		$273K Sell
2,023
-941
-32% -$138K 0.01% 212
2023
Q1 		$471K Sell
2,964
-249
-8% -$38.1K 0.01% 190
2022
Q4 		$520K Buy
3,213
+219
+7% +$33.6K 0.01% 164
2022
Q3 		$407K Buy
2,994
+954
+47% +$137K 0.01% 184
2022
Q2 		$312K Buy
2,040
+601
+42% +$91.8K 0.01% 208
2022
Q1 		$235K Sell
1,439
-462
-24% -$67.1K ﹤0.01% 260
2021
Q4 		$258K Sell
1,901
-812
-30% -$95.9K ﹤0.01% 276
2021
Q3 		$293K Buy
2,713
+487
+22% +$55.6K ﹤0.01% 269
2021
Q2 		$251K Buy
2,226
+1,522
+216% +$171K ﹤0.01% 304
2021
Q1 		$76K Buy
704
+56
+9% +$5.99K ﹤0.01% 499
2020
Q4 		$69K Sell
648
-59
-8% -$5.67K ﹤0.01% 462
2020
Q3 		$62K Buy
707
+198
+39% +$18.6K ﹤0.01% 543
2020
Q2 		$50K Sell
509
-196
-28% -$17.3K ﹤0.01% 531
2020
Q1 		$54K Sell
705
-767
-52% -$65.3K ﹤0.01% 471
2019
Q4 		$129K Sell
1,472
-3,670
-71% -$305K ﹤0.01% 465
2019
Q3 		$384K Buy
5,142
+1,565
+44% +$107K 0.01% 358
2019
Q2 		$256K Buy
3,577
+2,102
+143% +$165K 0.01% 433
2019
Q1 		$117K Sell
1,475
-16
-1% -$1.31K ﹤0.01% 490
2018
Q4 		$136K Sell
1,491
-13,375
-90% -$1.18M ﹤0.01% 433
2018
Q3 		$1.41M Buy
14,866
+6,497
+78% +$616K 0.03% 269
2018
Q2 		$768K Buy
8,369
+4,323
+107% +$422K 0.02% 275
2018
Q1 		$379K Sell
4,046
-712
-15% -$78.2K 0.01% 306
2017
Q4 		$457K Sell
4,758
-853
-15% -$80.4K 0.01% 231
2017
Q3 		$495K Sell
5,611
-1,341
-19% -$102K 0.01% 218
2017
Q2 		$504K Sell
6,952
-1,744
-20% -$117K 0.01% 199
2017
Q1 		$569K Sell
8,696
-1,637
-16% -$103K 0.01% 193
2016
Q4 		$648K Buy
+10,333
New +$631K 0.02% 168

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Migdal Insurance & Financial Holdings's ABBV Position: Q1 2026 in Review

Migdal Insurance & Financial Holdings increased its AbbVie (ABBV) stake by 24% in Q1 2026, buying an estimated $17.8M and bringing the position to 412,152 shares worth $89.6M. The position accounts for 0.78% of the portfolio, ranked #36.

Migdal Insurance & Financial Holdings first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Migdal Insurance & Financial Holdings held 412,152 shares of AbbVie worth $89.6M as of Q1 2026.
  • Migdal Insurance & Financial Holdings bought 80,450 AbbVie shares in Q1 2026, an estimated $17.8M.
  • AbbVie made up 0.78% of Migdal Insurance & Financial Holdings's portfolio in Q1 2026, its #36 holding.
  • Migdal Insurance & Financial Holdings first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2026, filed 14 May 2026.